department of pharmacology



Ferid Murad, M.D. Ph.D., Nobel Laureate

Professor & Director,
Institute of Molecular Medicine
The University of Texas
Health Science Center at Houston

Ferid Murad, M.D., Ph.D. won the 1998 Nobel Prize in Physiology or Medicine for his work with nitric oxide as a signaling molecule in the cardiovascular system. He and two co-recipients of the award, discovered how this colorless gas can be used to signal blood vessels to relax and widen, thus lowering blood pressure.

Dr. Murad earned his undergraduate degree in premedical science and chemistry from DePauw University in 1958 and received his M.D. and Ph.D. in Pharmacology from Case Western University in 1965 as one of the first combined degree M.D.-Ph.D. students in the U.S.

He completed an internship and residency in Medicine at Massachusetts General Hospital in Boston in 1967. Since that time, he has served as researcher at the NIH, professor and director of the Department of Clinical Pharmacology at the University of Virginia School of Medicine, Chief of Medicine at the Palo Alto Veterans Hospital, a Stanford University affiliate and later Chairman of Medicine at Stanford. In 1988, he became vice president at Abbott Laboratories, in charge of Pharmaceutical Research and Development. He left Abbott in 1993 to found Molecular Geriatrics Corporation. In 1997, Dr. Murad became the University of Texas-Houston¡¯s first chair of the Department of Integrative Biology, Pharmacology and Physiology. At the University of Texas Health Science Center at Houston, Dr. Murad is Regental Professor of the School of Medicine, Department of Integrative Biology and Pharmacology. He is also the Director of the Institute of Molecular Medicine for the Prevention of Human Diseases and the John S. Dunn Sr. Distinguished Chair in Physiology and Medicine. He is the recipient of many distinguished awards and was elected to the National Academy of Sciences.